NCT03364673

Brief Summary

This research study will test whether using wearable fitness trackers with a social incentive, delivered through a game-based mobile health intervention, increases physical activity and quality of life in ovarian cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable ovarian-cancer

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 6, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

July 20, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2020

Completed
10 months until next milestone

Results Posted

Study results publicly available

September 17, 2021

Completed
Last Updated

October 13, 2023

Status Verified

October 1, 2023

Enrollment Period

1.3 years

First QC Date

October 17, 2017

Results QC Date

June 28, 2021

Last Update Submit

October 7, 2023

Conditions

Keywords

Ovarian CancerPhysical ActivityMobile HealthFitness TrackerSurvivorshipQuality of Life

Outcome Measures

Primary Outcomes (3)

  • Feasibility of the Accelerometer + Social Support + Gamification

    Feasibility will be defined as ≥60% of patients who participate in the pilot study complete the 24-week intervention

    1 year pilot

  • Acceptability

    Study burden: To what extent do you agree or disagree with: "Participating in this study placed a substantial burden on me." (Options: strongly agree, agree, neutral, disagree, strongly disagree)

    24 weeks

  • Perceived Effectiveness

    To what extent do you agree or disagree with the following statements: "Participating in this study motivated me to increase my activity levels." Response options: strongly disagree, disagree, neutral, agree, strongly agree.

    24 weeks

Secondary Outcomes (2)

  • Change in Daily Steps From Baseline to 12 Weeks

    12 weeks [from end of baseline (day 15) to day 98]

  • Change in Daily Steps From Baseline 24 Weeks

    24 weeks [from end to baseline (day 15) to day 182]

Study Arms (1)

Fitness Tracker + Social Incentive Intervention

EXPERIMENTAL

Participants will enroll with a teammate (i.e. family or friend) and collaborate together. Teams will set a daily step goal, receive daily feedback on whether they achieved their goal, and receive a social incentive intervention.

Other: Fitness TrackerOther: Social Incentive (Way to Health)

Interventions

Fitness trackers (e.g. Fitbit) are accelerometers that are worn on the wrist and tracks users' heart rate continuously in addition to steps, distance, calories, and active minutes

Fitness Tracker + Social Incentive Intervention

The Way to Health platform is an automated information technology platform that integrates wireless devices, clinical trial randomization and enrollment processes, messaging (text, e-mail or voice), self-administered surveys, automatic transfers of financial incentives, and secure data capture for research purposes.

Fitness Tracker + Social Incentive Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients will be eligible if they have newly diagnosed ovarian cancer
  • Are ≤6 months of completing chemotherapy
  • Read English
  • Do not have cognitive, visual, or orthopedic impairments that would preclude participation
  • Plan to continue treatment at Dana-Farber Cancer Institute

You may not qualify if:

  • Participants will be excluded if they are already participating in an mHealth intervention
  • Are unable to ambulate
  • Do not have a smartphone to transmit data from the wearable tracker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dana Farber Cancer Institute

Boston, Massachusetts, 02215, United States

Location

Related Publications (1)

  • Schrier E, Xiong N, Thompson E, Poort H, Schumer S, Liu JF, Krasner C, Campos SM, Horowitz NS, Feltmate C, Konstantinopoulos PA, Dinardo MM, Tayob N, Matulonis UA, Patel M, Wright AA. Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors. Gynecol Oncol. 2021 May;161(2):581-586. doi: 10.1016/j.ygyno.2021.02.023. Epub 2021 Feb 23.

    PMID: 33637350BACKGROUND

MeSH Terms

Conditions

Ovarian NeoplasmsMotor Activity

Interventions

Fitness Trackers

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal DisordersBehavior

Intervention Hierarchy (Ancestors)

Diagnostic EquipmentEquipment and SuppliesWearable Electronic DevicesElectrical Equipment and Supplies

Limitations and Caveats

* Single-arm pilot study without a control group * Participants were recruited from a single academic center, were required to have a smartphone, and needed to be able to identify a teammate. This may have resulted in the selection of a more affluent, educated, and socially-connected population than is representative of ovarian cancer survivors nationwide. * We did not specifically measure other types of activity not captured by Fitbits (e.g., swimming or biking).

Results Point of Contact

Title
Alexi Wright, MD, MPH
Organization
Dana-Farber Cancer Institute

Study Officials

  • Alexi A. Wright, MD, MPH

    Dana-Farber Cancer Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicipal Investigator

Study Record Dates

First Submitted

October 17, 2017

First Posted

December 6, 2017

Study Start

July 20, 2018

Primary Completion

October 31, 2019

Study Completion

December 5, 2020

Last Updated

October 13, 2023

Results First Posted

September 17, 2021

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations